European Patent Office

T 1054/96 (Transgenic plant/NOVARTIS) of 13.10.1997

European Case Law Identifier
ECLI:EP:BA:1997:T105496.19971013
Date of decision
13 October 1997
Case number
T 1054/96
Petition for review of
-
Application number
91810144.5
IPC class
A01N 63/00
Language of proceedings
English
Distribution
Published in the EPO's Official Journal (A)
Abstracts for this decision
-
Application title
Anti-pathogenically effective composition comprising lytic peptides and hydrolytic enzymes
Applicant name
NOVARTIS AG
Opponent name
-
Board
3.3.04
Headnote

The following questions are referred to the Enlarged Board of Appeal for decision:

1. To what extent should the instances of the EPO examine an application in respect of whether the claims are allowable in view of the provision of Article 53(b) EPC that patents shall not be granted in respect of plant varieties or essentially biological processes for the production of plants, which provision does not apply to microbiological processes or the products thereof, and how should a claim be interpreted for this purpose?

2. Does a claim which relates to plants but wherein specific plant varieties are not individually claimed ipso facto avoid the prohibition on patenting in Article 53(b) EPC even though it embraces plant varieties?

3. Should the provisions of Article 64(2) EPC be taken into account when considering what claims are allowable?

4. Does a plant variety, in which each individual plant of that variety contains at least one specific gene introduced into an ancestral plant by recombinant gene technology, fall outside the provision of Article 53(b) EPC that patents shall not be granted in respect of plant varieties or essentially biological processes for the production of plants, which provision does not apply to microbiological processes or the products thereof?

Keywords
Claims encompassing plant varieties
Genetically engineered plant varieties
Essentially biological processes for the production of plants
Varieties as products of microbiological processes
Contravention of prohibition of Article 53(b) EPC
Referral to Enlarged Board (yes)
Catchword
-

ORDER

For these reasons it is decided that:

The following questions are referred to the Enlarged Board of Appeal for decision:

1. To what extent should the instances of the EPO examine an application in respect of whether the claims are allowable in view of the provision of Article 53(b) EPC that patents shall not be granted in respect of plant varieties or essentially biological processes for the production of plants, which provision does not apply to microbiological processes or the products thereof, and how should a claim be interpreted for this purpose?

2. Does a claim which relates to plants but wherein specific plant varieties are not individually claimed ipso facto avoid the prohibition on patenting in Article 53(b) EPC even though it embraces plant varieties?

3. Should the provisions of Article 64(2) EPC be taken into account when considering what claims are allowable?

4. Does a plant variety, in which each individual plant of that variety contains at least one specific gene introduced into an ancestral plant by recombinant gene technology, fall outside the provision of Article 53(b) EPC that patents shall not be granted in respect of plant varieties or essentially biological processes for the production of plants, which provision does not apply to microbiological processes or the products thereof?